TORONTO, ONTARIO, May 07, 2012 (MARKETWIRE via COMTEX) —
Attention: Business/Financial Editors
The Medipattern Corporation (“Medipattern” or the “Company”) (tsx
venture:MKI), announced today that SonoCare, LLC (“SonoCare”) has
received Visualize:Vascular(TM) and will begin offering the 3D
visualization procedure to patients through its 53 mobile sites
serving communities in North and South Carolina. SonoCare brings
cutting edge mobile imaging technology directly to the physician’s
office and direct to patients in residential settings. Their highly
qualified and experienced sonographers offer Ultrasound imaging
services to patients in the convenience and comfort of familiar
surroundings. SonoCare is dedicated to providing courteous, thorough,
and compassionate patient care of the highest quality with
uncompromised results and outstanding service. SonoCare is one of the
few companies in the Carolina’s that is accredited by the
Intersocietal Commission for the Accreditation of Echocardiography
Laboratories (“ICAEL”). This ICAEL accreditation was achieved because
of their commitment to quality patient care.
“We are very pleased to be the first vascular imaging company to
offer Visualize:Vascular in the Southeastern United States,” stated
Mark Schubring, Clinical Director of SonoCare. “Carotid artery
disease (“CAD”) is a major concern in our communities. SonoCare
performs a significant number of carotid duplex exams and screenings
each month to identify patients that may benefit from additional
medical attention. We believe that this 3D technology for ultrasound
will give us an edge for patients who are difficult to image.”
“SonoCare brings state of the art ultrasound imaging technology and
certified sonographers to the doctor’s offices that they serve. Their
outstanding American College of Radiology (“ACR”) accredited program
ensures exceptional patient care. Installation and training are
expected to be completed by the end of this quarter as each site is
phased in,” stated Jeff Collins, CEO The Medipattern Corporation. “We
continue to grow our installed base and scanning volume is expected
to continue to grow as we roll out our software throughout the
Southeastern United States. We are very pleased to work with SonoCare
and support their commitment to quality imaging procedures.”
Upcoming Events
Annual Meeting – MHA June 6 – 7, 2012 Brewster, MA
SVU/SVS Annual Conference June 7 – 9, 2012 Baltimore, MD
About the Medipattern Corporation:
Medipattern(R) is a pioneer in the development of imaging software
solutions that help medical practitioners to better understand
lesions and critical anatomy. Medipattern uses its Cadenza(TM)
technology to process images, finding the salient region of interest
and presenting them in 2D and 3D formats that enhance the reader’s
perception. For more information, please visit the Company’s website:
www.medipattern.com .
Medipattern(R) is a registered trademark of The Medipattern
Corporation. Cadenza(TM) is a trademark of the Medipattern
Corporation. SonoCine(R) is a registered trademark of SonoCine, Inc.
Forward-looking statements
This document contains forward-looking statements relating to
Medipattern’s performance, operations, or business environment. These
statements are based on what we believe are reasonable assumptions
given currently available information and our understanding of
Medipattern’s current activities. We have tried, whenever possible,
to identify these forward-looking statements using words such as
“anticipates,” “believes,” “estimates,” “expects,” “plans,”
“intends,” “potential”, and similar expressions. Forward-looking
statements are not guarantees of future performance and involve risks
and uncertainties that are difficult to predict or control. A number
of factors could cause actual outcomes and results to differ
materially from those expressed in forward-looking statements. These
factors include but are not limited to those set forth in the
Company’s corporate filings, (posted at
www.sedar.com ). In addition,
these forward-looking statements relate to the date on which they are
made. The Company disclaims any intention or obligation to update or
revise any forward-looking statements for any reason. Readers should
not rely on forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Contacts:
The Medipattern Corporation
Jeff Collins
CEO
(416) 744-0009 ext. 224
jcollins@medipattern.com
www.medipattern.com
Spinnaker Capital Markets Inc.
Kevin O'Connor
(416) 962-3300 ext. 226
ko@spinnakercmi.com
SOURCE: The Medipattern Corporation
mailto:jcollins@medipattern.com
https://www.medipattern.com mailto:ko@spinnakercmi.com
Copyright 2012 Marketwire, Inc., All rights reserved.
